Cargando…
Heterologous immunity induced by 1(st) generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine
Severe acute respiratory syndrome virus-2 (SARS-CoV-2), the causative infectious agent of the COVID-19 pandemic, has led to multiple (4-6) waves of infections worldwide during the past two years. The development of vaccines against SARS-CoV-2 has led to successful mass immunizations worldwide, mitig...
Autores principales: | Patel, Raj S., Agrawal, Babita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420909/ https://www.ncbi.nlm.nih.gov/pubmed/36045689 http://dx.doi.org/10.3389/fimmu.2022.952229 |
Ejemplares similares
-
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
por: Agrawal, Babita
Publicado: (2019) -
Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020) -
Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
por: Balz, Kathrin, et al.
Publicado: (2020) -
Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice
por: Patel, Raj S., et al.
Publicado: (2023) -
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
por: Gupta, Nancy, et al.
Publicado: (2018)